The price/operating cash flow metric for China Yuchai International Ltd is higher than merely 2.51% of stocks in our set with a positive cash flow.
CYD's price/sales ratio is 0.28; that's higher than the P/S ratio of just 5.75% of US stocks.
China Yuchai International Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 34.7%, greater than the shareholder yield of 93.82% of stocks in our set.
Stocks that are quantitatively similar to CYD, based on their financial statements, market capitalization, and price volatility, are AIN, RMTI, BHAT, FORTY, and ANY.
China Yuchai International Limited (CYD) Company Bio
China Yuchai International Limited manufactures and sells diesel and natural gas engines in the Peoples Republic of China (PRC) and other countries. The company was founded in 1951 and is based in Singapore.
CYD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for China Yuchai International Ltd. To summarize, we found that China Yuchai International Ltd ranked in the 86th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 802% on a DCF basis. The most interesting components of our discounted cash flow analysis for China Yuchai International Ltd ended up being:
Its compound free cash flow growth rate, as measured over the past 4.04 years, is -0.07% -- higher than merely 16.49% of stocks in our DCF forecasting set.
The company has produced more trailing twelve month cash flow than 86.7% of its sector Industrials.
China Yuchai International Ltd's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 8.9% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
ARC, SGRP, KEX, PGAS, and ULBI can be thought of as valuation peers to CYD, in the sense that they are in the Industrials sector and have a similar price forecast based on DCF valuation.
Article Thesis China Yuchai International Limited (CYD) has had a strong rally since mid-March lows – the stock price increased more than 120%. In addition to the sound results in the first three quarters, the main reason for CYD’s rapid gain in valuation was due to its significant undervaluation since...
Alborada Investments on Seeking Alpha | January 21, 2021
CytoDyn (CYD) has announced that the FDA has issued guidance to add an open-label extension to its Phase 3 trial (CD12) for Vyrologix™ (leronlimab-PRO 140) in severe-to-critically ill COVID-19 patients, including specific criteria for the continuation of eINDs for patients meeting the inclusion/exclusion criteria of CD12.The company expects to amend the trial...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.